Trials / Completed
CompletedNCT01670721
Colorectal Cancer Metastatic
A Multicenter, Single Arm, Open Label Clinical Trial Evaluating Safety and Health Related Quality of Life of Aflibercept in Combination With Irinotecan/5-FU Chemotherapy (FOLFIRI) in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 175 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: To evaluate the safety of aflibercept in participants with mCRC treated with irinotecan/5-Fluorouracil (5-FU) combination (FOLFIRI) after failure of an oxaliplatin-based regimen (participants similar to those evaluated in the VELOUR trial \[EFC10262, NCT00561470\]) according to side effects prevention and management guidelines. Secondary Objective: To document the Health-Related Quality of Life (HRQL) of aflibercept in this participant population.
Detailed description
Each participant was treated until disease progression (DP), unacceptable toxicity, death, Investigator's decision or participant's refusal for further treatment (whichever come first). Participants were followed-up during treatment and for at least 30 days after its last study treatment (either Aflibercept or FOLFIRI) administration, up to a maximum of 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AFLIBERCEPT | Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous |
| DRUG | Irinotecan | Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous |
| DRUG | Fluorouracil | Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous |
| DRUG | Leucovorin | Pharmaceutical form:Concentrate for solution for infusion; Route of administration: Intravenous |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2012-08-22
- Last updated
- 2016-11-28
- Results posted
- 2016-11-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01670721. Inclusion in this directory is not an endorsement.